Compare VKTX & BWLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VKTX | BWLP |
|---|---|---|
| Founded | 2012 | 1935 |
| Country | United States | Singapore |
| Employees | N/A | 1444 |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.3B |
| IPO Year | 2014 | N/A |
| Metric | VKTX | BWLP |
|---|---|---|
| Price | $35.70 | $21.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $95.86 | N/A |
| AVG Volume (30 Days) | ★ 2.2M | 342.6K |
| Earning Date | 04-29-2026 | 05-19-2026 |
| Dividend Yield | N/A | ★ 7.51% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $15.61 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.96 | $11.72 |
| 52 Week High | $43.15 | $22.92 |
| Indicator | VKTX | BWLP |
|---|---|---|
| Relative Strength Index (RSI) | 47.40 | 56.39 |
| Support Level | $33.65 | $19.33 |
| Resistance Level | $36.77 | $22.58 |
| Average True Range (ATR) | 1.86 | 0.57 |
| MACD | -0.65 | 0.20 |
| Stochastic Oscillator | 13.92 | 65.81 |
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
BW LPG Ltd is an owner and operator of very large gas carriers. It operates in two segments: the Shipping segment, which includes LPG shipping and the Product Services segment, which includes the core shipping business. The Product Services segment derives the majority of the revenue.